A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers

León-Cachón, Rafael B. R.; Ascacio-Martínez, Jorge A.; Gamino-Peña, María E.; Cerda-Flores, Ricardo M.; Meester, Irene; Gallardo-Blanco, Hugo L.; Gómez-Silva, Magdalena; Piñeyro-Garza, Everardo; Barrera-Saldaña, Hugo A.

doi:10.1186/s12885-016-2062-2

BMC Cancer

Article metrics
Last updated: Thu, 25 Apr 2024 21:38:49 Z

A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers

Access & Citations

2937

Article Accesses
23

Web of Science
21

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com